Trial Profile
Association of lenalidomide with subsequent primary malignancies in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 21 May 2015 New trial record